A dog lover who studied computer science and biology at Harvard, Ryan Boyko, 33, is the cofounder and CEO of Embark, a Boston-based company that tests dog DNA. He launched the company two years ago with his brother Adam, a Cornell University genetics professor who specializes in canines. In addition to details about a dog’s breed, for $199, Embark tests for more than 160 genetic conditions that can predict whether an animal will develop ailments like bladder stones, heart disease or glaucoma. Since it made the product available in late May 2016, Embark has made more than 20,000 sales. In this interview, which has been edited and condensed, Boyko tells how he got Embark off the ground.
Read the full story on Forbes: https://www.forbes.com/sites/forbestreptalks/2017/08/03/a-startup-embark-wants-to-be-a-23andme-for-dogs/?sh=32ae43eced71
Subscribe to FORBES: https://www.youtube.com/user/Forbes?sub_confirmation=1
Forbes newsletters: https://newsletters.editorial.forbes.com
Forbes on Facebook: http://fb.com/forbes
Forbes Video on Twitter: http://www.twitter.com/forbes
Forbes Video on Instagram: http://instagram.com/forbes
More From Forbes: http://forbes.com
Forbes covers the intersection of entrepreneurship, wealth, technology, business and lifestyle with a focus on people and success.
This Next Billion Dollar DNA Company Will Test Your Dog For A Healthier Life | Forbes